Revolutionizing Cancer Therapy Through CD39-Mediated Tumor Microenvironment Modulation
The following is a summary of “CD39 transforming cancer therapy by modulating tumor...
Read MoreJun 24, 2024
The following is a summary of “CD39 transforming cancer therapy by modulating tumor...
Read MoreJun 24, 2024
The most prevalent lacrimal apparatus dysfunctions associated with differentiated thyroid cancer(DTC) after I-131 therapy are dry eye and nasolacrimal duct obstruction(NLDO), leading to ocular discomfort and lower quality of...
Read MoreJun 24, 2024
The purpose of the present study was in vitro determination of the combined effects of doxorubucin and 5-fluorouracil by 2D and 3D culture conditions on breast cancer using MCF-7 cell line and CSCs isolated from these cells. In...
Read MoreJun 24, 2024
This is a case of a 67-year-old woman diagnosed with a 35-mm pancreatic body cancer with a chief complaint of epigastric discomfort. Computed tomography demonstrated invasion of the common hepatic artery, portal vein, and...
Read MoreJun 24, 2024
Ketone β-hydroxybutyrate (BHB) has been reported to prevent tumor cell proliferation and improve drug resistance. However, the effectiveness of BHB in oxaliplatin (Oxa)-resistant colorectal cancer (CRC) and the underlying...
Read MoreJun 24, 2024
Preserved ratio impaired spirometry (PRISm) and chronic obstructive pulmonary disease (COPD) belong to lung function injury. PRISm is a precursor to COPD. We compared and evaluated the different basic information, imaging...
Read MoreJun 23, 2024
Minimally invasive surgery (MIS) for cT4N0-1M0 NSCLC is safe, does not compromise survival rates, and results in shorter hospital stays compared with open surgery, according to a study in the European Journal of Cardio-Thoracic...
Read MoreJun 21, 2024
The following is a summary of “Incidence of chemotherapy-related cardiac dysfunction in cancer...
Read MoreJun 21, 2024
THURSDAY, June 20, 2024 (HealthDay News) — Cancer survivors who identify as lesbian, gay,...
Read MoreJun 20, 2024
The following is a summary of “Prognostic value of lymphocytes in patients with breast cancer...
Read MoreJun 20, 2024
The following is a summary of “Thyroid Cancer Prevalence, Risk Exposure, and Clinical...
Read MoreJun 20, 2024
The following is a summary of “Prognostic marker VPS72 could promote the malignant progression of...
Read MoreJun 20, 2024
Black patients are more likely to experience adverse cardiovascular outcomes after systemic...
Read MoreJun 19, 2024
The following is a summary of “A Systematic Methodology Review of Fluorescence-guided Cancer...
Read MoreJun 18, 2024
1. Treatment with osimertinib significantly improved progression-free survival, compared to...
Read MoreJun 18, 2024
1. No disease recurrences were observed during the median follow-up time of 26.2 months. 2....
Read MoreJun 17, 2024
1. Across a follow-up period of approximately 5 years, there was a non-linear relationship between...
Read MoreJun 17, 2024
Alzheimer’s disease (AD), breast cancer (BC) and prostate cancer (PC) continue to be high in the research and innovation agenda of the European Commission (EC). This is due to their exceptionally large burden to the...
Read MoreJun 17, 2024
Atherosclerosis and cancer may progress through common pathological factors. This study was performed to investigate the association between the abdominal aortic calcification (AAC) volume and outcomes following surgical...
Read MoreJun 17, 2024
To establish if osteosarcopenia is related to postoperative complications, prognosis, and recurrence of colorectal cancer (CRC) after curative surgery.The clinical data of 594 patients who underwent curative resection for CRC...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.